Patents by Inventor James Hardwick

James Hardwick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260004766
    Abstract: A method (100) of designing a segmented display device (1) having a plurality of elements (5) arranged in an array (3), each element (5) providing an individual output such that the plurality of elements (5) form a collective output of the device (1), wherein each element (5) is actuatable to control the individual output, the method (100) comprising: providing (102) a set (7) of images (9) representing a set of collective outputs from the device (1); generating (104) phase maps (13) of the images (9), the phase maps (13) having a phase value for each element (5) of the plurality of elements (5); and based on the phase maps (13), generating a plurality of non-overlapping groups of elements, wherein the elements (5) in each group are arranged to be actuated together as a segment (15) to cause display of any one of the set of collective output.
    Type: Application
    Filed: July 3, 2023
    Publication date: January 1, 2026
    Inventors: James Hardwick, Shubhi Bansal, Christable Choi, Sriram Subramanian, Talamali Salah, Panagiotis Florous
  • Publication number: 20110166028
    Abstract: The invention relates to the identification and use of gene expression profiles with clinical relevance to the treatment of cellular proliferative disorders, especially those mediated by aberrant Notch signaling using a Notch signaling inhibitor. In particular, the invention provides the identities of genes, whose individual or cumulative expression patterns may be useful in various assays. The gene expression profiles, whether embodied in nucleic acid expression, protein expression, or other expression formats, may be used to select subjects afflicted with a Notch mediated cancer who will likely respond to treatment with a gamma-secretase inhibitor or another Notch inhibiting agent. The same markers may be used in the classification of patients being treated with other Notch inhibitors. The methods may further comprise providing diagnostic, prognostic, or predictive information based on the classifying step. The methods may further comprise selecting a treatment based on the classifying step.
    Type: Application
    Filed: August 22, 2008
    Publication date: July 7, 2011
    Inventors: Donald Bergstrom, Xudong Dai, James Hardwick, Cole Liberator, A. Thomas Look, Jennifer O'Neil, Sudhir Rao, Peter Strack, Christopher Winter, Theresa Zhang
  • Publication number: 20060058227
    Abstract: The present invention is based on the key roles played by Hedgehog proteins in the regulation of homeostasis of the adult intestinal epithelium. Ihh is expressed in the adult mammalian colon and provides a lineage-instructive signal and regulates colonic epithelial morphogenesis in a compartmental fashion. Loss of Ihh expression precedes morphological change in colon tumorigenesis, i.e. carcinogenesis, and Ihh was absent in HT-29 colon carcinoma cells. Treatment of cancerous HT-29 cells with exogenous Hedgehog protein restored their differentiation. Ihh thus plays a pivotal role in the maintenance of colonic epithelial homeostasis in the differentiation of the GI tract cells and is essential for the enrolment of these GI tract cells on the Death program thus maintaining homeostasis to avoid or treat carcinogenesis. In addition, in gastric cancer expression of Shh is lost and loss of Shh expression precedes morphological changes in the parietal cells of the stomach.
    Type: Application
    Filed: February 20, 2003
    Publication date: March 16, 2006
    Applicant: Academisch Ziekenhulis bij de Universiteit van Amsterdam
    Inventors: Gijs Van Den Brink, Maikel Peppelenbosch, James Hardwick, Sander Jan Van Deventer